Search Results for

*

1-10 of 10 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Interventions to Increase Cervical Cancer Screening Rates - Cochrane for Clinicians - ...

Mar 1, 2012 - Invitation letters are the most studied method of encouraging cervical cancer screening, and they are effective (relative risk [RR] = 1.44; 95% confidence interval [CI], 1.24 to 1.52).1–3 Invitation letters may be more cost-effective than more intensive recruitment efforts (e.g., ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2012/0301/p443.html

Effect of Mammography on Breast Cancer Mortality - Cochrane for Clinicians - American ...

Dec 1, 2011 - Although mammography can lead to false-positive results, emotional stress, and unnecessary biopsies, it appears to reduce deaths from breast cancer by about 15 percent.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2011/1201/p1225.html

Screening for the Early Detection and Prevention of Oral Cancer - Cochrane for ...

May 1, 2011 - Screening by visual inspection of the oral cavity does not appear to reduce deaths from oral cancer in the general population, although there is some evidence that it could be effective in high-risk patients who use tobacco and alcohol.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2011/0501/p1047.html

Screening for Prostate Cancer: Prostate-Specific Antigen Testing Is Not Effective - ...

Apr 1, 2011 - Several large randomized controlled trials show that PSA screening does not significantly reduce prostate cancer mortality, even in a U.S. study that included black men and men with a family history of prostate cancer. However, PSA screening does lead to overdiagnosis, overtreatment, ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2011/0401/p802.html

Cancer Genetic Risk Assessment for Individuals at Risk of Familial Breast Cancer - ...

Feb 15, 2008 - Based on limited evidence from three trials, cancer genetic risk assessment reduces distress, improves accuracy of perceived breast cancer risk, and increases breast cancer and genetics knowledge.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2008/0215/p449.html

Counseling Women About Mammography: Benefits vs. Harms - Cochrane for Clinicians - ...

Sep 1, 2007 - Studies of mammography show a 0.1 percent absolute reduction in breast cancer mortality with mammography. This means that if 2,000 women are offered mammography over 10 years, one woman would have her life prolonged, 10 healthy women would be treated unnecessarily for breast cancer, and...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2007/0901/p652.html

Fecal Occult Blood Tests Reduce Colorectal Cancer Mortality - Cochrane for Clinicians -...

Jun 1, 2007 - Fecal occult blood testing reduces colorectal cancer mortality by 16 percent. Annual testing and rehydration of samples increases testing sensitivity but also increases the number of false-positive results.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2007/0601/p1652.html

Screening for Prostate Cancer - Cochrane for Clinicians - American Family Physician

Feb 1, 2007 - There is insufficient evidence to determine whether screening for prostate cancer reduces mortality or impacts quality of life.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2007/0201/p336.html

What Is the Best Collection Device for Screening Cervical Smears? - Cochrane for ...

Apr 1, 2004 - The combination of an extended-tip spatula with an endocervical brush (Cytobrush) is the most effective method for obtaining cervical cells. Detection of endocervical cells is a good indication of adequate smears and detection of disease.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2004/0401/p1661.html

Should We Offer Routine Breast Cancer Screening with Mammography? - Cochrane for ...

Jul 15, 2003 - While there is good evidence that mammography starting at age 50 reduces breast cancer mortality, this meta-analysis does not provide evidence of a mortality benefit for mammography screening in women aged 40 to 49. Controversy exists over whether to include in the analysis trials with ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2003/0715/p260.html

Page  1

25 50 100 results per page